benzoxazoles has been researched along with Genetic Predisposition in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Gospodinova, M; Kirov, A; Nakov, R; Nakov, V; Sarafov, S; Todorov, T; Todorova, A; Tournev, I | 1 |
Benbrahim, M; Hughes, D; Norman, K; Sanchorawala, V; Siddiqi, OK | 1 |
Bianchi, A; Mascalchi, M; Pastorelli, F; Rapezzi, C; Salvi, F; Vella, A; Volpe, R | 1 |
Grogan, DR; Judge, DP; Merlini, G; Obici, L; Packman, J; Perlini, S; Planté-Bordeneuve, V; Schmidt, H; Tripp, T | 1 |
Aarts, J; Berthet, K; Damy, T; Judge, DP; Kristen, AV; Li, H | 1 |
1 review(s) available for benzoxazoles and Genetic Predisposition
Article | Year |
---|---|
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
Topics: Amyloid Neuropathies, Familial; Animals; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Diflunisal; Genetic Predisposition to Disease; Humans; Mutation; Oligonucleotides; Phenotype; Prealbumin; RNA, Small Interfering; Treatment Outcome | 2021 |
2 trial(s) available for benzoxazoles and Genetic Predisposition
Article | Year |
---|---|
Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis.
Topics: Adult; Aged; Amyloid; Amyloid Neuropathies, Familial; Benzoxazoles; Disease Progression; Europe; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Phenotype; Prealbumin; Time Factors; Treatment Outcome; United States | 2013 |
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis.
Topics: Adult; Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Europe; Female; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Middle Aged; Mutation; Myocardium; Phenotype; Prealbumin; Risk Factors; Time Factors; Treatment Outcome; United States | 2015 |
2 other study(ies) available for benzoxazoles and Genetic Predisposition
Article | Year |
---|---|
Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report.
Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Chronic Disease; Diagnosis, Differential; Diarrhea; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Prealbumin; Predictive Value of Tests | 2019 |
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Topics: Adult; Amyloid Neuropathies, Familial; Benzoxazoles; Blindness; Brain Ischemia; Cerebrovascular Disorders; Disease Progression; Eye Diseases; Female; Genetic Predisposition to Disease; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Mutation; Phenotype; Prealbumin; Siderosis; Treatment Failure; Ultrasonography | 2018 |